Author

E. Morava

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

E. O. Perlstein· 1 shared F. S. Sam· 1 shared G. Preston· 1 shared H. Tsang· 1 shared J. Lao· 1 shared J. Verhejein· 1 shared K. Murthy· 1 shared N. DiPrimio· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

E. O. Perlstein

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG

S. Iyer, F. S. Sam, N. DiPrimio, G. Preston, J. Verhejein, K. Murthy, Z. Parton, H. Tsang, J. Lao, E. Morava, E. O. Perlstein

This paper identifies epalrestat, an existing drug, as a PMM2 enzyme activator for PMM2-CDG, showing it improves enzyme activity in patient fibroblasts.

bioRxiv · Sep 26, 2019Pharmacology & Toxicology